The Akershus Study of Ischemic Stroke and Thrombolysis -1

NCT05378490 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 6000

Last updated 2025-02-05

No results posted yet for this study

Summary

This observational study comprises consecutively patients with cerebrovascular diseases admitted to the Stroke Unit at Akershus University Hospital in Norway. Akershus University Hospital is the largest emergency care hospital in Norway and has a catchment area covering a population of 550.000, which is approximately 10 % of the Norwegian population and reasonably representative according to data from Statistics Norway. The hospital is public and serving both as a primary hospital and a university hospital. Due to the Norwegian, national, all-covering health-insurance, all patients enter the hospital and are considered for further in-patient care on the same conditions. The hospital has a stroke unit classified as a comprehensive stroke center according to European Stroke Organisation standards. Acute stroke management follows national and international guidelines. Overall, the ASIST-1 study will investigate management, outcome and prognosis of stroke and stroke care pathways and later follow up in primary care using several approaches combining existing clinical data from a representative population with different Norwegian health registries. Parts of the study are retrospective with prospective follow-up by health registries and parts of the study are prospective.

Conditions

  • Stroke, Acute
  • Intracerebral Hemorrhage
  • Stroke, Ischemic
  • TIA

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER
  • Oslo University Hospital

    collaborator OTHER
  • University Hospital, Akershus

    lead OTHER

Principal Investigators

  • Espen S. Kristoffersen, MD, PhD · University Hospital, Akershus

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2025-12-31
Completion
2040-12-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05378490 on ClinicalTrials.gov